- Areas of Interest
- Techniques
- Systems
- Products & Services
- Informatics
- Science & Education
- Company
- Support
Neuroscience researchers are using NGS to identify variants for a new sequencing array designed for ADHD, autism, and schizophrenia studies.
Read Article
Landmark NGS study leads to a national clinical diagnostic exome sequencing platform in Singapore.
Read Article
A robust genotyping solution that’s flexible, scalable, and works from DNA to data analysis ...
View VideoVisit booth 2621 to explore limitless possibilities
Learn MoreHow to estimate the depth of sequencing coverage needed for your research
Learn MoreIllumina offers webinars and free online training courses to get the most out of your experiments and products
View WebinarsView CoursesOn Demand
Consortium aims to expand access to high-quality clinical whole genome sequencing for genetic diseases
Read Article| Date | Publication | Title |
|---|---|---|
| 27/02/2019 | Bloomberg | A $100 Genome Within Reach, Illumina CEO Asks If World Is Ready |
| 27/02/2019 | Slate | Why Are We So Afraid of Each New Advance in Reproductive Technology? |
| 19/02/2019 | San Diego Union Tribune | San Diego biotech company teams up with doctors to offer genome sequencing to Tijuana children |